Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T18:48:11.181Z.
Calculation as of: 2026-10-06T18:48:11.181Z.
Quote observation: 2026-10-06T18:45:11.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1f6c3cb5bbb3974cb57aa01d91c7ccd9ef46dc872eab4c8e1bf0feb963fbdb06
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2025-08-06.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
12.21x
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Entrada Therapeutics, Inc.
Market Cap
$210.80M
EV/EBITDA Ratio
N/A
TTM Avg
12.21x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$207.67M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$207.94M
EV/EBITDA Ratio
15.14x
TTM Avg
13.21x
3Y Avg
12.70x
5Y Avg
13.38x
Market Cap
$214.24M
EV/EBITDA Ratio
14.36x
TTM Avg
22.76x
3Y Avg
55.61x
5Y Avg
55.61x
Market Cap
$206.11M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$214.85M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$214.64M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | $210.80M | N/A | 12.21x | N/A | N/A |
| Compugen Ltd. (CGEN)vs › | $211.33M | N/A | 6.24x | 9.83x | 9.83x |
| Electra Therapeutics Inc. (ETRA)vs › | $207.67M | N/A | N/A | N/A | N/A |
| Pro-Dex, Inc. (PDEX)vs › | $207.94M | 15.14x | 13.21x | 12.70x | 13.38x |
| Lyell Immunopharma, Inc. (LYEL)vs › | $213.92M | N/A | N/A | N/A | N/A |
| Niagen Bioscience Inc (NAGE)vs › | $214.24M | 14.36x | 22.76x | 55.61x | 55.61x |
| Sionna Therapeutics, Inc. (SION)vs › | $206.11M | N/A | N/A | N/A | N/A |
| Anbio Biotechnology Class A Ordinary Shares (NNNN)vs › | $214.85M | N/A | N/A | N/A | N/A |
| Prelude Therapeutics Incorporated (PRLD)vs › | $214.64M | N/A | N/A | N/A | N/A |
| Whitehawk Therapeutics Inc (WHWK)vs › | $205.52M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2025-08-06 | 29.59x |
| 2025-08-05 | 28.97x |
| 2025-08-04 | 29.43x |
| 2025-08-01 | 28.81x |
| 2025-07-31 | 29.23x |
| 2025-07-30 | 33.18x |
| 2025-07-29 | 31.36x |
| 2025-07-28 | 31.05x |
| 2025-07-25 | 32.66x |
| 2025-07-24 | 31.88x |
| 2025-07-23 | 31.88x |
| 2025-07-22 | 31.83x |
| 2025-07-21 | 30.58x |
| 2025-07-18 | 31.20x |
| 2025-07-17 | 31.83x |
| 2025-07-16 | 31.83x |
| 2025-07-15 | 31.78x |
| 2025-07-14 | 34.01x |
| 2025-07-11 | 32.71x |
| 2025-07-10 | 33.80x |
| 2025-07-09 | 38.02x |
| 2025-07-08 | 35.89x |
| 2025-07-07 | 34.90x |
| 2025-07-03 | 36.25x |
| 2025-07-02 | 36.46x |
| 2025-07-01 | 35.63x |
| 2025-06-30 | 33.60x |
| 2025-06-27 | 34.59x |
| 2025-06-26 | 35.16x |
| 2025-06-25 | 35.37x |
| 2025-06-24 | 35.47x |
| 2025-06-23 | 35.26x |
| 2025-06-20 | 35.68x |
| 2025-06-18 | 35.21x |
| 2025-06-17 | 36.15x |
| 2025-06-16 | 37.19x |
| 2025-06-13 | 38.12x |
| 2025-06-12 | 39.48x |
| 2025-06-11 | 39.74x |
| 2025-06-10 | 41.61x |
| 2025-06-09 | 40.83x |
| 2025-06-06 | 41.92x |
| 2025-06-05 | 40.88x |
| 2025-06-04 | 39.89x |
| 2025-06-03 | 41.51x |
| 2025-06-02 | 40.99x |
| 2025-05-30 | 38.18x |
| 2025-05-29 | 39.74x |
| 2025-05-28 | 39.06x |
| 2025-05-27 | 38.70x |
| 2025-05-23 | 37.66x |
| 2025-05-22 | 38.28x |
| 2025-05-21 | 38.64x |
| 2025-05-20 | 41.51x |
| 2025-05-19 | 40.31x |
| 2025-05-16 | 40.73x |
| 2025-05-15 | 40.88x |
| 2025-05-14 | 40.10x |
| 2025-05-13 | 43.90x |
| 2025-05-12 | 44.52x |
| 2025-05-09 | 42.23x |
| 2025-05-08 | 6.48x |
| 2025-05-07 | 6.09x |
| 2025-05-06 | 6.23x |
| 2025-05-05 | 6.88x |
| 2025-05-02 | 7.00x |
| 2025-05-01 | 6.84x |
| 2025-04-30 | 6.91x |
| 2025-04-29 | 6.75x |
| 2025-04-28 | 6.69x |
| 2025-04-25 | 6.67x |
| 2025-04-24 | 6.77x |
| 2025-04-23 | 6.56x |
| 2025-04-22 | 6.56x |
| 2025-04-21 | 5.91x |
| 2025-04-17 | 6.06x |
| 2025-04-16 | 5.84x |
| 2025-04-15 | 5.84x |
| 2025-04-14 | 5.89x |
| 2025-04-11 | 5.87x |
| 2025-04-10 | 5.83x |
| 2025-04-09 | 6.18x |
| 2025-04-08 | 5.57x |
| 2025-04-07 | 6.12x |
| 2025-04-04 | 5.90x |
| 2025-04-03 | 5.97x |
| 2025-04-02 | 6.63x |
| 2025-04-01 | 6.60x |
| 2025-03-31 | 6.84x |
| 2025-03-28 | 7.28x |
| 2025-03-27 | 7.62x |
| 2025-03-26 | 7.57x |
| 2025-03-25 | 7.80x |
| 2025-03-24 | 8.33x |
| 2025-03-21 | 8.07x |
| 2025-03-20 | 8.00x |
| 2025-03-19 | 8.29x |
| 2025-03-18 | 8.04x |
| 2025-03-17 | 8.34x |
| 2025-03-14 | 8.34x |
| 2025-03-13 | 8.35x |
| 2025-03-12 | 8.68x |
| 2025-03-11 | 8.20x |
| 2025-03-10 | 8.07x |
| 2025-03-07 | 8.30x |
| 2025-03-06 | 8.01x |
| 2025-03-05 | 8.14x |
| 2025-03-04 | 8.49x |
| 2025-03-03 | 8.78x |
| 2025-02-28 | 9.29x |
| 2025-02-27 | 7.67x |
| 2025-02-26 | 7.69x |
| 2025-02-25 | 7.76x |
| 2025-02-24 | 8.24x |
| 2025-02-21 | 8.37x |
| 2025-02-20 | 8.39x |
| 2025-02-19 | 8.34x |
| 2025-02-18 | 8.40x |
| 2025-02-14 | 8.64x |
| 2025-02-13 | 8.10x |
| 2025-02-12 | 8.14x |
| 2025-02-11 | 7.84x |
| 2025-02-10 | 8.25x |
| 2025-02-07 | 8.30x |
| 2025-02-06 | 8.66x |
| 2025-02-05 | 9.00x |
| 2025-02-04 | 8.71x |
| 2025-02-03 | 8.56x |
| 2025-01-31 | 8.64x |
| 2025-01-30 | 8.59x |
| 2025-01-29 | 8.52x |
| 2025-01-28 | 8.38x |
| 2025-01-27 | 8.46x |
| 2025-01-24 | 8.24x |
| 2025-01-23 | 8.29x |
| 2025-01-22 | 8.04x |
| 2025-01-21 | 8.38x |
| 2025-01-17 | 8.14x |
| 2025-01-16 | 8.04x |
| 2025-01-15 | 7.85x |
| 2025-01-14 | 8.01x |
| 2025-01-13 | 8.59x |
| 2025-01-10 | 9.44x |
| 2025-01-08 | 10.48x |
| 2025-01-07 | 11.16x |
| 2025-01-06 | 11.69x |
| 2025-01-03 | 11.86x |
| 2025-01-02 | 11.30x |
| 2024-12-31 | 11.19x |
| 2024-12-30 | 11.24x |
| 2024-12-27 | 11.27x |
| 2024-12-26 | 11.49x |
| 2024-12-24 | 11.37x |
| 2024-12-23 | 11.30x |
| 2024-12-20 | 11.39x |
| 2024-12-19 | 11.18x |
| 2024-12-18 | 11.06x |
| 2024-12-17 | 11.96x |
| 2024-12-16 | 11.66x |
| 2024-12-13 | 11.43x |
| 2024-12-12 | 11.74x |
| 2024-12-11 | 12.92x |
| 2024-12-10 | 13.32x |
| 2024-12-09 | 13.99x |
| 2024-12-06 | 14.04x |
| 2024-12-05 | 13.20x |
| 2024-12-04 | 12.96x |
| 2024-12-03 | 13.10x |
| 2024-12-02 | 13.20x |
| 2024-11-29 | 12.91x |
| 2024-11-27 | 12.87x |
| 2024-11-26 | 12.57x |
| 2024-11-25 | 12.35x |
| 2024-11-22 | 12.19x |
| 2024-11-21 | 11.69x |
| 2024-11-20 | 11.61x |
| 2024-11-19 | 11.51x |
| 2024-11-18 | 11.29x |
| 2024-11-15 | 11.56x |
| 2024-11-14 | 12.35x |
| 2024-11-13 | 12.96x |
| 2024-11-12 | 12.84x |
| 2024-11-11 | 12.91x |
| 2024-11-08 | 12.86x |
| 2024-11-07 | 12.47x |
| 2024-11-06 | 12.09x |
| 2024-11-05 | 5.58x |
| 2024-11-04 | 5.27x |
| 2024-11-01 | 5.20x |
| 2024-10-31 | 5.04x |
| 2024-10-30 | 5.07x |
| 2024-10-29 | 5.09x |
| 2024-10-28 | 5.12x |
| 2024-10-25 | 4.98x |
| 2024-10-24 | 4.93x |
| 2024-10-23 | 4.97x |
| 2024-10-22 | 5.03x |
| 2024-10-21 | 5.10x |
| 2024-10-18 | 5.15x |
| 2024-10-17 | 5.22x |
| 2024-10-16 | 5.23x |
| 2024-10-15 | 5.18x |
| 2024-10-14 | 5.29x |
| 2024-10-11 | 4.90x |
| 2024-10-10 | 4.55x |
| 2024-10-09 | 4.68x |
| 2024-10-08 | 4.76x |
| 2024-10-07 | 4.82x |
| 2024-10-04 | 5.01x |
| 2024-10-03 | 4.78x |
| 2024-10-02 | 4.72x |
| 2024-10-01 | 4.62x |
| 2024-09-30 | 4.61x |
| 2024-09-27 | 4.78x |
| 2024-09-26 | 4.53x |
| 2024-09-25 | 4.27x |
| 2024-09-24 | 4.40x |
| 2024-09-23 | 4.09x |
| 2024-09-20 | 4.13x |
| 2024-09-19 | 4.25x |
| 2024-09-18 | 3.76x |
| 2024-09-17 | 3.94x |
| 2024-09-16 | 4.09x |
| 2024-09-13 | 4.25x |
| 2024-09-12 | 4.20x |
| 2024-09-11 | 4.20x |
| 2024-09-10 | 4.15x |
| 2024-09-09 | 4.26x |
| 2024-09-06 | 4.18x |
| 2024-09-05 | 4.39x |
| 2024-09-04 | 4.40x |
| 2024-09-03 | 4.49x |
| 2024-08-30 | 5.24x |
| 2024-08-29 | 5.17x |
| 2024-08-28 | 4.73x |
| 2024-08-27 | 4.87x |
| 2024-08-26 | 4.95x |
| 2024-08-23 | 4.81x |
| 2024-08-22 | 4.66x |
| 2024-08-21 | 4.79x |
| 2024-08-20 | 4.96x |
| 2024-08-19 | 4.81x |
| 2024-08-16 | 4.81x |
| 2024-08-15 | 4.71x |
| 2024-08-14 | 4.55x |
| 2024-08-13 | 20.32x |
| 2024-08-12 | 18.26x |
| 2024-08-09 | 18.01x |
| 2024-08-08 | 18.57x |
| 2024-08-07 | 17.74x |
| 2024-08-06 | 18.88x |
| 2024-08-05 | 18.58x |
| 2024-08-02 | 18.96x |
| 2024-08-01 | 20.52x |
| 2024-07-31 | 21.18x |
| 2024-07-30 | 21.73x |
| 2024-07-29 | 21.46x |
| 2024-07-26 | 22.14x |
| 2024-07-25 | 21.99x |
| 2024-07-24 | 20.79x |
Showing the most recent 260 of 312 data points. The chart above shows the full history.
